MedPath

The effect of propolis dietary supplement on the status of hs-CRP inflammatory index, sex hormone testosterone levels and metabolic profile of women with polycystic ovary syndrome

Phase 3
Conditions
Polycystic ovarian syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20121216011763N51
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
56
Inclusion Criteria

Diagnosis of PCOS according to Rotterdam criterion: According to this criterion, the subjects should have two of the three diagnostic features of PCOS: 1- Oligomenorrhea and anovulation 2- Hyperandrogenism 3- Polycystic ovary
Age between 18 and 45 years
Not to have sensitivity to bee products
Not to take any specific drug more than metformin
Not to have laparoscopic ovarian surgery and assisted reproductive technology

Exclusion Criteria

Hormone therapy or taking contraceptive pills (OCP)
History of gestational hypertension
Pregnancy or breastfeeding
Menopause
Tobacco and alcohol consumption
Having following diseases: Diabetes, cardiovascular, hepatic, renal, thyroid, asthma, neoplasm

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Homeostatic model assessment of insulin resistance (HOMA-IR). Timepoint: Before study and 12 weeks after supplementation. Method of measurement: formula= (fasting plasma glucose(mmol/l) *fasting insulin (IU/ml))/22.5.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath